Chronic Kidney Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Kidney Disease stocks.

Recent Signals

Date Stock Signal Type
2021-03-03 AZN Lower Bollinger Band Walk Weakness
2021-03-03 IDH 20 DMA Support Bullish
2021-03-03 IDH 50 DMA Resistance Bearish
2021-03-03 IDH Stochastic Buy Signal Bullish
2021-03-03 IDH MACD Bullish Signal Line Cross Bullish
2021-03-03 IDH Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-03-03 STX New 52 Week Low Weakness
2021-03-03 STX NR7 Range Contraction
2021-03-03 STX Doji - Bullish? Reversal
2021-03-03 STX Lower Bollinger Band Walk Weakness
2021-03-03 STX Calm After Storm Range Contraction

Recent News for Chronic Kidney Disease Stocks

Date Stock Title
Mar 4 AZN UK regulator says will fast-track vaccines for coronavirus variants
Mar 4 AZN AZN BREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline – AZN
Mar 3 AZN Lawsuits Filed Against AZN, XOM and EH - Jakubowitz Law Pursues Shareholders Claims
Mar 3 AZN COVID SCIENCE-T cell response to virus variants remains potent; Asthma does not raise severe COVID-19 risk
Mar 3 AZN Doctor: Health care workers are ‘frustrated and concerned’ over lifting of virus mandates
Mar 3 AZN Lifting restrictions without a fully vaccinated population is gambling: Doctor
Mar 3 AZN HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts AstraZeneca (AZN) Investors to Securities Fraud Lawsuit Application Deadline, Encourages Investors Who Suffered Losses to Contact the Firm
Mar 3 AZN Hungary to extend AstraZeneca jabs to people over 60, official says
Mar 3 AZN The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SWI, AZN and FUBO
Mar 3 AZN EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters
Mar 3 AZN The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TCDA, AZN and XOM
Mar 3 AZN Senegal receives its first AstraZeneca vaccines under COVAX
Mar 3 AZN AstraZeneca Just Sold Its Moderna Stock: Should You?
Mar 3 AZN Interim UK study finds one dose of COVID shots reduces hospitalisation
Mar 3 AZN UPDATE 1-Germany seeks to extend AstraZeneca jabs to over 65s soon
Mar 3 AZN UPDATE 1-S.Korea probes deaths of two who received AstraZeneca COVID-19 vaccine
Mar 3 AZN First COVID-19 vaccines arrive in Taiwan
Mar 2 AZN The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLUE, AZN and XOM
Mar 2 AZN Doctor: Even as vaccines progress ‘we can’t let our guard down’
Mar 2 AZN SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms. Later, leg swelling, feeling tired, vomiting, loss of appetite, or confusion may develop. Complications may include heart disease, high blood pressure, bone disease, or anemia.Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of the condition. Diagnosis is generally by blood tests to measure the glomerular filtration rate and urine tests to measure albumin. Further tests such as an ultrasound or kidney biopsy may be done to determine the underlying cause. A number of different classification systems exist.Screening at-risk people is recommended. Initial treatments may include medications to manage blood pressure, blood sugar, and lower cholesterol. NSAIDs should be avoided. Other recommended measures include staying active and certain dietary changes. Severe disease may require hemodialysis, peritoneal dialysis, or a kidney transplant. Treatments for anemia and bone disease may also be required.Chronic kidney disease affected 753 million people globally in 2016, including 417 million females and 336 million males. In 2015 it resulted in 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

More about Chronic Kidney Disease
Browse All Tags